Skip to main content
. Author manuscript; available in PMC: 2018 Dec 1.
Published in final edited form as: Support Care Cancer. 2018 Jun 4;26(12):4105–4113. doi: 10.1007/s00520-018-4281-3

Table 3.

Commonly Deprescribed Medication Classes

Medication Class Potential Adverse Events Prevented
Vitamins/minerals (n=18) Pill burden, ineffectiveness, drug interactions
Antihypertensives (n=11) Fatigue, orthostatic hypotension, dizziness, falls
Statins (n=8) Fatigue, myalgias, myopathies, lack of benefit
Benzodiazepines (n=7) CNS depression, falls, delirium, somnolence
Aspirin/NSAIDS (n=6) Gastrointestinal bleeding, lack of benefit
Proton pump inhibitors (n=6) Hypocalcemia, hypomagnesemia, fractures, infections, chronic kidney disease, dementia
Omega-3 fatty acids (n=5) Increase bleeding risk, pill burden
Electrolyte supplements (n=5) Pill burden
Other (n=21) Various adverse drug effects